MedTrace Logo

The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)

NCT02804464 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-03-08

No results posted yet for this study

Summary

Demonstrate that the Karius Infectious Disease Diagnostic Sequencing Assay performed on plasma can accurately detect the microbiologic etiology in febrile allogeneic stem-cell transplant patients when compared with standard clinical diagnostics

Conditions

  • Bone Marrow Transplant Infection

Sponsors & Collaborators

Principal Investigators

  • Peter Chin-Hong, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2022-07-31
Completion
2023-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02804464 on ClinicalTrials.gov